CHMP Nod Little Consolation As Amgen's Imlygic Becomes Melanoma Also-Ran
This article was originally published in The Pink Sheet Daily
Executive Summary
Europe's top scientific panel gives positive review to product (also known as T-VEC) for advanced melanoma but the treatment landscape has been transformed by innovative competitors over the past few years.